Award
National Cancer Institute 5R37CA258761-05
Ms. LILAC: Muscle Mass in the Life and Longevity After Cancer (LILAC) Study
Recipient
State University of New York at Buffalo, Amherst, NY
Award Amount
$607,165.00
Ceiling
$607,165.00
Awarded
April 13, 2026
Identifier
5R37CA258761-05
The Ms. LILAC study aims to measure muscle mass in postmenopausal women, including cancer survivors and controls, using a novel remote method. The research will inform public health strategies to prevent low muscle mass and improve health outcomes in aging cancer survivors.
Description
This project will provide the first-ever direct measure of muscle mass in a large sample of community dwelling postmenopausal women using the D3-creatine method, a highly accurate and scalable measure of muscle mass that can be carried out remotely (at home). This novel approach will be used to compare the antecedents and consequences of low muscle mass in cancer survivors and age-matched cancer-free controls. This research will contribute to the development of public health recommendations and intervention strategies to prevent low muscle mass and associated adverse health outcomes in older and long-term cancer survivors.